Key Points
- McKesson CAO Napoleon Rutledge Jr. sold 111 shares at an average price of $891.45, totaling $98,950.95. The transaction, conducted under a pre-arranged Rule 10b5-1 plan, reduced his direct ownership by 17.56% to 521 shares.
- McKesson reported quarterly EPS of $9.93, beating estimates of $9.56, while revenue rose 7.7% year over year to $105.38 billion. The company issued FY 2027 EPS guidance of $44.20–$45.00.
- The company raised its quarterly dividend from $0.82 to $0.94 per share, implying an annualized dividend of $3.76 and a 0.4% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $973.44.
McKesson Corporation (NYSE:MCK - Get Free Report) CAO Napoleon Rutledge, Jr. sold 111 shares of the business's stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total value of $98,950.95. Following the completion of the transaction, the chief accounting officer directly owned 521 shares of the company's stock, valued at $464,445.45. The trade was a 17.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
McKesson Price Performance
Shares of NYSE MCK opened at $881.22 on Friday. The stock has a market capitalization of $102.74 billion, a price-to-earnings ratio of 23.58, a PEG ratio of 1.77 and a beta of 0.30. The firm's 50 day simple moving average is $858.30 and its 200-day simple moving average is $840.99. McKesson Corporation has a 12 month low of $687.68 and a 12 month high of $999.00.
McKesson (NYSE:MCK - Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The firm had revenue of $105.38 billion during the quarter, compared to analysts' expectations of $103.88 billion. During the same period in the previous year, the business posted $8.26 EPS. The business's revenue was up 7.7% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. Analysts anticipate that McKesson Corporation will post 44.65 earnings per share for the current fiscal year.
McKesson Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be paid a dividend of $0.94 per share. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Tuesday, September 1st. This is an increase from McKesson's previous quarterly dividend of $0.82. McKesson's dividend payout ratio is currently 10.06%.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on MCK. Wells Fargo & Company upped their price target on McKesson from $812.00 to $933.00 and gave the stock an "equal weight" rating in a report on Tuesday, August 11th. TD Cowen upped their target price on McKesson from $989.00 to $1,006.00 and gave the stock a "buy" rating in a research note on Thursday, August 6th. Robert W. Baird set a $1,015.00 target price on McKesson in a research report on Thursday, August 6th. Weiss Ratings raised shares of McKesson from a "buy (b-)" rating to a "buy (b)" rating in a report on Friday, September 4th. Finally, Citigroup lifted their target price on shares of McKesson from $945.00 to $1,000.00 and gave the company a "buy" rating in a research report on Friday, July 24th. Fourteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $973.44.
Read Our Latest Analysis on MCK
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the company. University of Texas Texas AM Investment Management Co. purchased a new stake in shares of McKesson during the 4th quarter valued at approximately $25,000. Swiss RE Ltd. acquired a new stake in shares of McKesson in the fourth quarter valued at $26,000. Delos Wealth Advisors LLC purchased a new stake in shares of McKesson in the 2nd quarter valued at $27,000. State of Wyoming acquired a new position in McKesson during the 2nd quarter worth about $29,000. Finally, Kingdom Financial Group LLC. purchased a new position in McKesson during the 4th quarter valued at about $33,000. 85.07% of the stock is owned by institutional investors and hedge funds.
McKesson Company Profile
(
Get Free Report)
McKesson Corporation is a healthcare services and distribution company that supplies pharmaceuticals, specialty drugs, medical products and related services to pharmacies, hospitals, health systems, physicians and other healthcare providers. Its operations support the movement of prescription medicines and medical-surgical supplies from manufacturers to healthcare organizations and patients.
The company's businesses include pharmaceutical distribution, specialty pharmaceutical services, medical-surgical supply distribution and technology solutions for pharmacies and other healthcare providers.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
